Divisadero Street Capital Management’s Apyx Medical APYX Stock Holding History

Divisadero Street Capital Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,146	Closed	-$38.9K	–	60
2023 Q3	$38.9K	Sell	12,146 -2,271,812	-99%	-$10.6M	0.01%	49
2023 Q2	$11.5M	Buy	+2,283,958	New	+$11.6M	3.32%	10
2022 Q3	–	Sell	-202,470	Closed	-$1.19M	–	43
2022 Q2	$1.19M	Buy	+202,470	New	+$1.04M	0.42%	37

Other funds holding APYX

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Divisadero Street Capital Management's APYX Position: Q4 2023 in Review

Divisadero Street Capital Management sold out of Apyx Medical (APYX) in Q4 2023, closing a stake of 12,146 shares — an estimated $38.9K sold.

Divisadero Street Capital Management first reported a position in APYX in Q2 2022 and held it in 3 quarters. The position peaked at $11.5M in Q2 2023. 62 funds tracked by Wall St. Rank hold APYX as of Q4 2023.

Divisadero Street Capital Management reported no remaining Apyx Medical position as of Q4 2023 after selling out during the quarter.
Divisadero Street Capital Management sold 12,146 Apyx Medical shares in Q4 2023, an estimated $38.9K.
Divisadero Street Capital Management first reported a position in Apyx Medical in Q2 2022 and held it in 3 quarters.
Divisadero Street Capital Management's Apyx Medical position peaked at $11.5M in Q2 2023.
62 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2023.

Based on Divisadero Street Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.